Interwest Venture Management CO Applied Genetic Technologies Corp Transaction History

Interwest Venture Management CO

  • $20.6 Million
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 27, 2021
SELL
$3.99 - $5.7 $205,042 - $292,917
-51,389 Reduced 3.53%
1,404,515 $5.74 Million
Q3 2017

Oct 11, 2017
BUY
$3.55 - $5.25 $5.17 Million - $7.64 Million
1,455,904
1,455,904 $5.75 Million

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Interwest Venture Management CO Portfolio

Follow Interwest Venture Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interwest Venture Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Interwest Venture Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email